Home
/
MYRIAD GENETICS INC
/
Financials
/
Quarterly
MYRIAD GENETICS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that MYRIAD GENETICS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Mar 31, 2018
$193.50M
May 9, 2018
Q2
2018
Dec 31, 2017
$194.00M
Feb 7, 2018
Q1
2018
Sep 30, 2017
$190.20M
Nov 8, 2017
Q3
2018
Mar 31, 2017
$196.90M
May 9, 2018
Q2
2018
Dec 31, 2016
$196.50M
Feb 7, 2018
Q1
2018
Sep 30, 2016
$177.50M
Nov 8, 2017
Q3
2017
Mar 31, 2016
$190.50M
May 3, 2017
Q2
2017
Dec 31, 2015
$193.30M
Feb 8, 2017
Q1
2017
Sep 30, 2015
$183.50M
Nov 2, 2016
Q3
2016
Mar 31, 2015
$180.00M
May 4, 2016
Q2
2016
Dec 31, 2014
$184.40M
Feb 3, 2016
Q1
2016
Sep 30, 2014
$168.80M
Nov 4, 2015
Q3
2015
Mar 31, 2014
$182.92M
May 6, 2015
Q2
2015
Dec 31, 2013
$204.06M
Feb 4, 2015
Q1
2015
Sep 30, 2013
$202.47M
Nov 5, 2014
Q3
2014
Mar 31, 2013
$156.47M
May 7, 2014
Q2
2014
Dec 31, 2012
$149.14M
Feb 5, 2014
Q1
2014
Sep 30, 2012
$133.44M
Nov 12, 2013
Q3
2013
Mar 31, 2012
$129.78M
May 8, 2013
Q2
2013
Dec 31, 2011
$122.81M
Feb 6, 2013
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$205.70M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$213.10M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$195.90M
May 7, 2025
Q3
2025
Sep 30, 2024
$213.30M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$211.50M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$202.20M
May 7, 2025
Q3
2024
Sep 30, 2023
$191.90M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$183.50M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$181.20M
May 8, 2024
Q3
2023
Sep 30, 2022
$156.40M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$179.30M
Aug 4, 2023
Q1
2023
Mar 31, 2022
$164.90M
May 4, 2023
Q3
2022
Sep 30, 2021
$167.30M
Nov 2, 2022
Q2
2022
Jun 30, 2021
$189.40M
Aug 5, 2022
Q1
2022
Mar 31, 2021
$173.10M
May 6, 2022
Q3
2021
Sep 30, 2020
$145.20M
Nov 4, 2021
Q1
2021
Sep 30, 2020
$145.20M
Nov 9, 2020
Q2
2021
Jun 30, 2020
$93.20M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$164.00M
May 5, 2021
Q3
2020
Mar 31, 2020
$164.00M
May 6, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($27.40M)
Nov 4, 2025
Q3
2025
Jun 30, 2025
($330.50M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($330.50M)
Aug 6, 2025
Q2
2025
Mar 31, 2025
($100.0K)
Aug 6, 2025
Q3
2025
Mar 31, 2025
($100.0K)
Nov 4, 2025
Q1
2025
Mar 31, 2025
($100.0K)
May 7, 2025
Q3
2025
Sep 30, 2024
($22.10M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($36.70M)
Aug 6, 2025
Q3
2025
Jun 30, 2024
($36.70M)
Nov 4, 2025
Q2
2025
Mar 31, 2024
($26.00M)
Aug 6, 2025
Q3
2025
Mar 31, 2024
($26.00M)
Nov 4, 2025
Q1
2025
Mar 31, 2024
($26.00M)
May 7, 2025
Q3
2024
Sep 30, 2023
($61.30M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($116.10M)
Aug 7, 2024
Q3
2024
Jun 30, 2023
($116.10M)
Nov 8, 2024
Q2
2024
Mar 31, 2023
($54.70M)
Aug 7, 2024
Q3
2024
Mar 31, 2023
($54.70M)
Nov 8, 2024
Q1
2024
Mar 31, 2023
($54.70M)
May 8, 2024
Q3
2023
Sep 30, 2022
($35.10M)
Nov 7, 2023
Q3
2023
Jun 30, 2022
($14.10M)
Nov 7, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($23.30M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($329.20M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($29.00M)
May 7, 2025
Q3
2025
Sep 30, 2024
($20.00M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($36.50M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($27.90M)
May 7, 2025
Q3
2024
Sep 30, 2023
($60.10M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($113.70M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($52.20M)
May 8, 2024
Q3
2023
Sep 30, 2022
($45.00M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($17.80M)
Aug 4, 2023
Q1
2023
Mar 31, 2022
($25.60M)
May 4, 2023
Q3
2022
Sep 30, 2021
($79.90M)
Nov 2, 2022
Q2
2022
Jun 30, 2021
($20.80M)
Aug 5, 2022
Q1
2022
Mar 31, 2021
($46.70M)
May 6, 2022
Q3
2021
Sep 30, 2020
($39.60M)
Nov 4, 2021
Q1
2021
Sep 30, 2020
($39.60M)
Nov 9, 2020
Q2
2021
Jun 30, 2020
($68.30M)
Aug 4, 2021
Q3
2020
Mar 31, 2020
($133.70M)
May 6, 2020
Q1
2021
Mar 31, 2020
($133.70M)
May 5, 2021